Nuti Francesca, Marinari Eliana, Erdei Edit, El-Hamshari Manal, Echavarria Mirna Guadalupe, Ars Elisabet, Balercia Giancarlo, Merksz Miklos, Giachini Claudia, Shaeer Kamal Zaki Mahmoud, Forti Gianni, Ruiz-Castané Eduard, Krausz Csilla
Andrology Unit, Department of Clinical Physiopathology, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy.
J Clin Endocrinol Metab. 2008 Mar;93(3):1072-6. doi: 10.1210/jc.2007-1993. Epub 2007 Dec 11.
Insulin-like 3 and its receptor, leucine-rich repeat-containing G protein-coupled receptor 8 (LGR8), are essential for the first phase of testicular descent. Homozygous loss of either of the two genes in mice leads to cryptorchidism. Although mutations in both homologous human genes are not a common cause of cryptorchidism. To date, only one missense mutation at codon 222 (T222P) of the LGR8 gene has been proposed as a causative mutation for cryptorchidism. This conclusion was based on both functional in vitro studies and the lack of mutation in a large group of controls. The geographical origin of the mutation carriers suggested a founder effect in the Mediterranean area.
We sought to define the frequency of the T222P mutation in four different countries to assess whether the screening for this mutation could be of use as a diagnostic genetic test.
A total of 822 subjects (359 with a history of cryptorchidism and 463 controls) from Italy, Spain, Hungary, and Egypt were genotyped for the T222P mutation by direct sequencing.
The phenotypical expression of the mutation also included normal testicular descent. The mutation frequency was not significantly different in cryptorchid patients vs. noncryptorchid controls (3.6 vs. 1.7%, respectively). No significant geographical differences were observed in mutation frequencies. The haplotype analysis allowed us to predict three distinct haplotypes, i.e. three possible mutation events.
Our results suggest that the T222P mutation cannot be considered either causative or a susceptibility factor for cryptorchidism. A true causative mutation in the LGR8 gene still remains to be identified.
胰岛素样3及其受体富含亮氨酸重复序列的G蛋白偶联受体8(LGR8)对睾丸下降的第一阶段至关重要。小鼠中这两个基因之一的纯合缺失会导致隐睾症。尽管人类这两个同源基因的突变并非隐睾症的常见病因。迄今为止,仅LGR8基因第222密码子处的一个错义突变(T222P)被认为是隐睾症的致病突变。这一结论基于体外功能研究以及一大组对照中未发现该突变。突变携带者的地理起源提示在地中海地区存在奠基者效应。
我们试图确定四个不同国家中T222P突变的频率,以评估对该突变进行筛查是否可作为一种诊断性基因检测方法。
通过直接测序对来自意大利、西班牙、匈牙利和埃及的总共822名受试者(359名有隐睾症病史者和463名对照)进行T222P突变基因分型。
该突变的表型表达还包括正常的睾丸下降。隐睾症患者与非隐睾症对照的突变频率无显著差异(分别为3.6%和1.7%)。在突变频率上未观察到显著的地理差异。单倍型分析使我们能够预测三种不同的单倍型,即三种可能的突变事件。
我们的结果表明,T222P突变不能被视为隐睾症的致病因素或易感因素。LGR8基因真正的致病突变仍有待确定。